Vitalhub Corp.
TSX:VHI.TOMedical - Healthcare Information Services
+$0.04 today
- Market cap
- $421.84M
- Beta
- 0.77
- P/E (TTM)
- 62.1
- EPS (TTM)
- $0.12
Volume 0.23M
Average 0.41M
VHI.TO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Vitalhub Corp.TSX: VHI.TO
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of CA$7.76M rose 110.5% year over year, ahead of the +96.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 7.1% from the prior quarter. Over 3 fiscal years it compounded at +64.2% a year.
Context
- EBITDA amounted to 21.3% of revenue in FY2025, up 4.0 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 7 analysts of CA$20.78M (-10.6%) for the fiscal year ending Dec 2026, a slowdown from the +95.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- CA$7.76M+7.1% QoQ
- Last fiscal yearDec 2025
- CA$23.25M+95.3% YoY
- LTMMar 2026
- CA$24.15M+96.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +110.5% | +119.8% | +9.3 pp |
| 1 year | +95.3% | -10.6% | -106.0 pp |
| 3-year CAGR | +64.2% | +8.2% | -56.1 pp |
| 5-year CAGR | +3.6% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
CAD · from the income statement
- Latest · FY2025
- 23.25M CAD
- Year-over-year change
- +95.3%
- 4-year CAGR
- +113.7%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 23.25M | +95.3% |
| FY2024 | 2024-12-31 | 11.9M | +14.7% |
| FY2023 | 2023-12-31 | 10.38M | +97.7% |
| FY2022 | 2022-12-31 | 5.25M | +370.7% |
| FY2021 | 2021-12-31 | 1.12M | — |
EBITDA vs competitors
How VHI.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +96.3% is the 2nd highest of 7, against a peer median of -3.6%.
- EBITDA amounts to 20.3% of revenue for VHI.TO, versus a peer median of 21.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$65.18M CAD | -6.0% | +29.1% | 12.8% | |
| LTM Mar 2026 | $60.46M USD | +510.4% | — | 23.1% | |
| LTM Mar 2026 | $25.12M USD | +96.0% | +26.0% | 49.3% | |
| LTM Mar 2026 | CA$24.15M CAD | +96.3% | +64.2% | 20.3% | |
| LTM Mar 2026 | CA$12.62M CAD | -1.2% | — | 19.0% | |
| LTM Mar 2026 | CA$9.82M CAD | -80.9% | — | 3.1% | |
| LTM Mar 2026 | -CA$35.21M CAD | -81.6% | — | 1275.3% | |
| Peer median (excluding VHI.TO) | — | -3.6% | +27.6% | 21.0% | |
Competitors are the stored peer set for VHI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 24.66M | 39.97M | 52.51M | 68.59M | 108.97M |
| Cost of Revenue | 5.24M | 7.03M | 9.7M | 13.1M | 32.46M |
| Gross Profit | 19.43M | 32.94M | 42.81M | 55.49M | 76.51M |
| Gross Margin | 78.8% | 82.4% | 81.5% | 80.9% | 70.2% |
| Research & Development | 6.05M | 10.43M | 12.17M | 15.23M | 28.95M |
| Selling, General & Admin | 10.41M | 13.97M | 18.8M | 24.56M | 35.39M |
| Operating Expenses | 19.13M | 28.28M | 42.81M | 45.75M | 64.34M |
| Depreciation & Amortization | 2.68M | 3.87M | 4.98M | 5.96M | 11.08M |
| EBITDA | 1.12M | 5.25M | 10.38M | 11.9M | 23.25M |
| EBITDA Margin | 4.5% | 13.1% | 19.8% | 17.4% | 21.3% |
| Operating Income | 324.33K | 4.66M | 6.86M | 9.74M | 12.17M |
| Operating Margin | 1.3% | 11.7% | 13.1% | 14.2% | 11.2% |
| Interest Income | 29.55K | 0 | 489.57K | 1.95M | 2.42M |
| Interest Expense | 82.43K | 70.35K | 71.98K | 43.01K | 70.35K |
| Other Income / Expenses | (1.94M) | (6.28M) | (1.53M) | (3.85M) | (6.27M) |
| Income Before Tax | (1.61M) | 1.31M | 5.33M | 5.9M | 5.9M |
| Pre-Tax Margin | -6.5% | 3.3% | 10.1% | 8.6% | 5.4% |
| Income Tax Expense | 333.08K | 92.08K | 778.25K | 2.9M | (209.56K) |
| Net Income | (1.95M) | 1.21M | 4.55M | 3M | 6.11M |
| Net Margin | -7.9% | 3.0% | 8.7% | 4.4% | 5.6% |
| EPS (Basic) | (0.05) | 0.03 | 0.10 | 0.06 | 0.10 |
| EPS (Diluted) | (0.05) | 0.03 | 0.10 | 0.06 | 0.10 |
| Weighted Avg Shares | 36.4M | 41.49M | 43.65M | 49.2M | 58.54M |
| Weighted Avg Shares (Diluted) | 36.4M | 42.56M | 46.6M | 50.93M | 60.29M |
Vitalhub Corp.
TSX:VHI.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.66
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.